全文获取类型
收费全文 | 183篇 |
免费 | 19篇 |
国内免费 | 4篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 11篇 |
口腔科学 | 104篇 |
临床医学 | 23篇 |
内科学 | 3篇 |
皮肤病学 | 6篇 |
特种医学 | 1篇 |
外科学 | 3篇 |
综合类 | 3篇 |
预防医学 | 13篇 |
药学 | 36篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 3篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 18篇 |
2012年 | 7篇 |
2011年 | 8篇 |
2010年 | 3篇 |
2009年 | 5篇 |
2008年 | 6篇 |
2007年 | 10篇 |
2006年 | 8篇 |
2005年 | 20篇 |
2004年 | 7篇 |
2003年 | 8篇 |
2002年 | 7篇 |
2001年 | 6篇 |
2000年 | 1篇 |
1999年 | 2篇 |
1998年 | 3篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 9篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 2篇 |
排序方式: 共有206条查询结果,搜索用时 46 毫秒
1.
目的 预测三氯生治疗非酒精性脂肪性肝病(NAFLD)的作用,为深入研究三氯生改善NAFLD的靶点与机制提供线索。方法 采用网络药理学的方法获取三氯生作用靶点和NAFLD疾病靶点,映射得到三氯生与NAFLD共同靶点;构建共同靶点的蛋白质网络图,计算Degree值筛选出三氯生改善NAFLD的潜在靶点,利用分子对接技术验证三氯生与潜在靶点的结合性,并通过基因本体(GO)分析和京都基因与基因组百科全书(KEGG)信号通路富集分析预测三氯生治疗NAFLD关键靶点。采用高脂饲料喂养C57BL/6J雄鼠12周建立NAFLD模型后使用400 mg/(kg·d)剂量的三氯生灌胃8周,使用HE和油红O染色分别观察小鼠肝组织病理变化和脂肪沉积情况,采用蛋白质免疫印迹法检测肝组织中过氧化物酶体增殖物激活受体α(PPARα)蛋白表达水平的变化。结果 网络药理学初步预测到34个三氯生与NAFLD的共同靶点,蛋白质网络分析显示白蛋白(ALB)、丝裂原激活蛋白激酶8(MAPK8)、PPARα、脂肪酸合成酶等19个靶点Degree值高于平均值,可能是三氯生治疗NAFLD的潜在靶点;分子对接显示19个靶点中ALB、MAPK8、PPARα与三氯生结合能最低;KEGG分析结果显示靶点富集于过氧化物酶体增殖物激活受体信号通路,ALB、MAPK8并未参与。实验结果显示三氯生减少NAFLD小鼠肝脏HE染色出现的气球样变和脂滴空泡,降低肝脏油红O染色的脂滴面积,提高小鼠肝脏组织中PPARα的表达水平。结论 三氯生可以改善NAFLD肝脏病变,PPARα极可能是三氯生治疗NAFLD的关键靶点,可能通过过氧化物酶体增殖物激活受体信号通路参与脂肪酸氧化发挥治疗NAFLD的作用。 相似文献
2.
Triclosan exhibits a tendency to accumulate in the epididymis and shows sperm toxicity in male sprague‐dawley rats 下载免费PDF全文
Zhou Lan Tae Hyung Kim Kai Shun Bi Xiao Hui Chen Hyung Sik Kim 《Environmental toxicology》2015,30(1):83-91
Triclosan (TCS) is considered a potent endocrine disruptor that causes reproductive toxicity in non‐mammals, but it is still unclear exactly whether TCS has adverse effects on the sperm or reproductive organs in mammals. In this study, we aimed to evaluate the distribution status of TCS in male reproductive organs of rats, and seek the correlation with the TCS‐induced sperm toxicity or reproductive organ damage. Male rats were intragastrically administered with TCS at a dose of 50 mg/kg, the kinetics of TCS in the plasma and reproductive organs were investigated. TCS in testes and prostates both showed a lower‐level distritbution compared to that in the plasma, which indicates it has no tendency to accumulate in those organs. However, TCS in the epididymides showed a longer elimination half‐life (t1/2z), a longer the mean retention time (MRT), and a lower clearance (CLZ/F) compared with those in the plasma. Besides, the ratios of mean area under the concentration‐time curve (AUC)0–96h(epididymides/plasma) and AUC0–∞(epididymides/plasma) were 1.13 and 1.51, respectively. These kinetic parameters suggest TCS has an accumulation tendency in the epididymides. Based on this, we investigated the TCS‐induced sperm toxicity and histopathological changes of reproductive organs in rats. TCS was given intragastrically at doses of 10, 50, and 200 mg/kg for 8 weeks. Rats treated with the high dose (200 mg/kg) of TCS showed a significant decrease in daily sperm production (DSP), changes in sperm morphology and epididymal histopathology. Considering the histopathological change in the epididymides, TCS may induce the epididymal damage due to the epididymal accumulation of that. © 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 83–91, 2015. 相似文献
3.
The Influence of Triclosan on Biomarkers of Cardiovascular Risk in Patients in the Cardiovascular and Periodontal Study (CAPS): A Randomized Controlled Trial 下载免费PDF全文
Mary P. Cullinan Janet E. Palmer Malcolm J. Faddy Bill Westerman Anne D. Carle Malcolm J. West Gregory J. Seymour 《Journal of periodontology》2015,86(7):847-855
Background: Triclosan toothpaste is effective in controlling plaque and gingivitis and slowing progression of periodontitis; however, its influence on inflammatory biomarkers of cardiovascular disease (CVD), as well as on kidney and liver function, is unknown. Methods: Patients recruited from the Cardiovascular Unit at Prince Charles Hospital, Brisbane, Australia, were randomized to triclosan (n = 193) or placebo (n = 190) groups and assessed for total cholesterol (TC), high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol, triglycerides, C‐reactive protein, erythrocyte sedimentation rate (ESR), hemoglobin, total white cell count (WCC), estimated glomerular filtration rate (eGFR), and liver function enzymes, annually for 5 years. A standard mixed model for each marker included group, sex, age, hypertension, diabetes, periodontal status, statin and anti‐inflammatory drug use, and smoking as covariates. Changes in eGFR, WCC, and ESR were further analyzed using transition modeling. Results: Triclosan toothpaste led to a greater decrease in TC (P = 0.03), LDL cholesterol (P = 0.04), and HDL cholesterol (P = 0.05) than placebo toothpaste. ESR increased at a slower rate in the triclosan group (P ≈ 0.06) and was less likely to increase and more likely to improve in males on statins but not anti‐inflammatory drugs in the triclosan group versus the placebo group. Markov modeling of the binary response for eGFR (greater than or less than/equal to the baseline median value) showed that patients with diabetes in the placebo group were significantly (P ≈ 0.05) more likely to deteriorate than either patients with diabetes in the triclosan group or patients without diabetes in each group. Conclusions: These data suggest that triclosan toothpaste may influence some inflammatory biomarkers of CVD, but not kidney or liver function. However, it is unclear if this influence is clinically significant. 相似文献
4.
M. P. Cullinan P. S. Bird N. C. K. Heng M. J. West G. J. Seymour 《Journal of periodontal research》2014,49(2):220-225
Background and Objective
There is a paucity of data in relation to the possible emergence of triclosan (TCS)‐resistant bacteria following long‐term exposure to TCS toothpaste. Therefore, this study investigated whether long‐term continuous exposure to TCS in toothpaste selects for TCS‐resistant bacteria within the oral biofilm.Material and Methods
Dental plaque samples were collected from 40 individuals during year 5 of a randomised controlled trial. Participants had been randomly assigned to use TCS (3000 μg/mL TCS) (n = 18) or placebo toothpaste (n = 22). Diluted plaque samples were plated on to Wilkins–Chalgren agar plates containing 5% (v/v) laked sheep red blood cells and TCS (concentrations ranging from 25 to 150 μg/mL) and incubated at 37°C under microaerophilic and anaerobic conditions for 2–10 d. Selected bacterial isolates were identified by partial 16S rDNA sequencing and TCS minimum inhibitory concentration (MIC) determined for each isolate.Results
At 3000 μg/mL TCS no growth was observed under microaerophilic or anaerobic conditions in either group. The MICs of TCS for all isolates ranged from 125 to 1000 μg/mL in both groups. Species common to both groups had similar MICs. Veillonella parvula and Campylobacter gracilis were the most frequent isolates from both groups, with similar MICs in both groups.Conclusion
The use of TCS‐containing toothpaste did not appear to lead to an increase in MIC of TCS of oral bacterial isolates. 相似文献5.
Pera C Ueda P Casarin RC Ribeiro FV Pimentel SP Casati MZ Cirano FR 《Journal of periodontology》2012,83(7):909-916
Background: This study evaluates the effect of triclosan/copolymer dentifrice on the 6‐month clinical response of patients with generalized severe chronic periodontitis (GSCP) treated with one‐stage, full‐mouth ultrasonic debridement (FMUD). Methods: Thirty patients diagnosed with GSCP (≥8 teeth presenting probing depth [PD] ≥5 mm and bleeding on probing [BOP]) were selected and randomly allocated to a control group (n = 15) subjected to FMUD and daily use of a placebo dentifrice or to a test group (n = 15) subjected to FMUD and daily use of a triclosan/copolymer dentifrice. Patients were analyzed for the following parameters: full‐mouth plaque index (FMPI), full‐mouth BOP score (FMBS), gingival recession, PD, and clinical attachment level (CAL). Patients were evaluated at 3 and 6 months by a calibrated and masked examiner. Results: Initially, the groups presented similar periodontal conditions, with no significant differences in any of the parameters evaluated (P >0.05). In both groups, improvements in all periodontal parameters (P <0.05) were seen at the completion of the experimental period. Additionally, the test group showed lower FMPI (3 months) and FMBS (3 and 6 months) than the control group (P <0.05). Moreover, the CAL gain was significantly greater in the test group, especially at initially deep pockets (PD ≤7 mm). Whereas in the control group the CAL gain in deep pockets was 2.7 ± 0.6 mm, in the test group the CAL gain was 3.6 ± 1.4 mm (P <0.05). Conclusion: Within the limits of the present study, the use of triclosan/copolymer dentifrice promoted additional clinical benefits in the treatment of GSCP treated by one‐stage FMUD. 相似文献
6.
7.
JIA-LONG Fang ROBIN L. STINGLEY FREDERICK A. BELAND WAFA HARROUK DEBBIE L. LUMPKINS PAUL HOWARD 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2013,31(3):147-171
Triclosan has broad-spectrum anti-microbial activity against most gram-negative and gram-positive bacteria. It is widely used in personal care products, household items, medical devices, and clinical settings. Due to its extensive use, there is potential for humans in all age groups to receive life-time exposures to triclosan, and, indeed, triclosan has been detected in human tissues and the environment. Data gaps exist regarding the chronic dermal toxicity and carcinogenicity of triclosan, which is needed for the risk assessment of triclosan. The US Food and Drug Administration (FDA) nominated triclosan to the National Toxicology Program (NTP) for toxicological evaluations. Currently, the NTP is conducting several dermal toxicological studies to determine the carcinogenic potential of triclosan, evaluate its endocrine and developmental-reproductive effects, and investigate the potential UV-induced dermal formation of chlorinated phenols and dioxins of triclosan. This paper reviews data on the human exposure, environmental fate, efficacy of anti-microbial activity, absorption, distribution, metabolism and elimination, endocrine disrupting effects, and toxicity of triclosan. 相似文献
8.
9.
Palmer RK Hutchinson LM Burpee BT Tupper EJ Pelletier JH Kormendy Z Hopke AR Malay ET Evans BL Velez A Gosse JA 《Toxicology and applied pharmacology》2012,258(1):99-108
Triclosan is a broad-spectrum antibacterial agent, which has been shown previously to alleviate human allergic skin disease. The purpose of this study was to investigate the hypothesis that the mechanism of this action of triclosan is, in part, due to effects on mast cell function. Mast cells play important roles in allergy, asthma, parasite defense, and carcinogenesis. In response to various stimuli, mast cells degranulate, releasing allergic mediators such as histamine. In order to investigate the potential anti-inflammatory effect of triclosan on mast cells, we monitored the level of degranulation in a mast cell model, rat basophilic leukemia cells, clone 2H3. Having functional homology to human mast cells, as well as a very well defined signaling pathway leading to degranulation, this cell line has been widely used to gain insight into mast-cell driven allergic disorders in humans. Using a fluorescent microplate assay, we determined that triclosan strongly dampened the release of granules from activated rat mast cells starting at 2 μM treatment, with dose-responsive suppression through 30 μM. These concentrations were found to be non-cytotoxic. The inhibition was found to persist when early signaling events (such as IgE receptor aggregation and tyrosine phosphorylation) were bypassed by using calcium ionophore stimulation, indicating that the target for triclosan in this pathway is likely downstream of the calcium signaling event. Triclosan also strongly suppressed F-actin remodeling and cell membrane ruffling, a physiological process that accompanies degranulation. Our finding that triclosan inhibits mast cell function may explain the clinical data mentioned above and supports the use of triclosan or a mechanistically similar compound as a topical treatment for allergic skin disease, such as eczema. 相似文献
10.
Pratibha G. Kakadia 《Journal of microencapsulation》2013,30(7-8):695-704
AbstractHealthcare-associated infections (HAIs) are a concern for health service providers, exacerbated by poor delivery of antimicrobials to target sites within the skin. The dermal route is attractive for local and systemic delivery of drugs, however; permeation, penetration, and access to deeper skin layers are restricted due to the barrier function of the stratum corneum (SC). Solid lipid nanoparticles present several benefits for topical delivery for therapeutic applications, especially via the follicular route. Hair follicles, surrounded by a close network of blood capillaries and dendritic cells, are an important target for delivery of antimicrobials and present a unique microbial nidus for endogenous infections in situations where the barrier is disrupted, such as after surgery, for example, triclosan, a broad-spectrum antimicrobial agent, was encapsulated into nanoparticles using glyceryl behenate and glyceryl palmitostearate (GP) solid lipids, and incorporating Transcutol P, a known permeation enhancer at different ratios. Optimised formulation was stable over 90?d and in vitro permeation studies using full thickness porcine ear skin showed that the lipid-based nanoparticles enhanced delivery of triclosan into the skin and could direct the agent towards hair follicles, indicating their potential as a carrier system for antiseptic dermal delivery. 相似文献